Comparing imaging techniques for oral health in patients with infective endocarditis
Official title: 3D Imaging (Cone Beam Computed Tomography) Versus Orthopantomogram on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis: a Multicenter Randomized Superiority Controlled Trial.
Run by Nantes University Hospital · NCT06269679 · Data updated 2026-11-12
This study is testing if a special type of dental scan called Cone Beam Computed Tomography can find oral infections better than a regular dental X-ray in patients with infective endocarditis to help improve their oral health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 10 sites (Bordeaux and 9 other locations) |
| Status | Recruiting |
| Started | December 18, 2024 |
| Main results expected | July 18, 2028 |
| Study ends | July 18, 2028 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT06269679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are hospitalized for definite infective endocarditis and have a stable clinical state.
✕Probably not a fit
Patients who have already undergone OPT or CBCT imaging prior to the study or have medical contraindications for these imaging techniques may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of Cone Beam Computed Tomography (CBCT) compared to traditional Orthopantomogram (OPT) in detecting Oral Infectious Foci (OIF) in patients hospitalized for infective endocarditis (IE). Given that streptococci of oral origin are a common cause of IE, the study will assess whether the enhanced sensitivity of CBCT can lead to better oral health outcomes and potentially reduce new episodes of IE. Patients will be randomly assigned to receive either imaging technique during their hospitalization, and their oral health status will be monitored over a 12-month period.
Why it matters
Potential benefit: If successful, this study could lead to improved detection and management of oral infections in patients with infective endocarditis, potentially reducing morbidity and mortality associated with the condition.
How similar studies have gone: While this approach is novel in the context of infective endocarditis, similar imaging techniques have shown promise in other dental and medical studies for detecting oral infections.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients hospitalized or recently hospitalized for definite IE according to the 2015 ESC classification, naive patients for dental examination and imaging, whatever the IE responsible microorganism; 2. Patients with a stable clinical state, meaning stabilized IE patients out of the critical phase, compatible with the performance of an OPT and a CBCT; 3. Patients whose life expectancy is expected to be longer than 6 months; 4. Patients who agree to visit the dental department of the hospital to carry out OIF eradication or at his/her personal dentist; 5. Patients over 18 years old; 6. Patients affiliated to a Social Security or a health insurance scheme; 7. Patients who have given informed consent to participate to the study. Exclusion Criteria: 1. OPT or CBCT already performed before the inclusion of the patients in the study and available for the investigator during the patient's hospitalization. 2. Medical contraindications to perform OPT or CBCT imaging; 3. Absence of microbiologic identification of the IE responsible microorganism; 4. Pregnant or breastfeeding women; 5. Patients unable to give informed consent to participate to the study (under trusteeship, guardianship and legal protection).
Where it's running
-
CHU Bordeaux - Site Pellegrin
Bordeaux, France Recruiting -
CHU Clermont-Ferrand
Clermont-Ferrand, France Recruiting -
CHU Grenoble
Grenoble, France Recruiting -
Hcl
Lyon, France Recruiting -
Aphm
Marseille, France Recruiting -
CHRU Nancy
Nancy, France Recruiting
Show 4 more locations
-
CHU Nantes
Nantes, France Recruiting -
AP-HP - Site Bretonneau
Paris, France Recruiting -
CHU Toulouse
Toulouse, France Recruiting -
CHRU Tours
Tours, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Al[18F]F-NOTA-folate PET imaging in suspected cardiac sarcoidosis and infective endocarditis
This diagnostic test uses a folate-based PET tracer to see if it can help identify inflammation or infection in the heart for people with suspected cardiac sarcoidosis or infective endocarditis.
-
Etiologic Diagnosis Algorithm in Infective Endocarditis
Aiming to see if a combined culture and molecular testing approach can help doctors choose the right antibiotics faster for adults with infective endocarditis.
-
Rifampin-free therapy vs rifampin-containing therapy for staphylococcal prosthetic valve endocarditis
This study tests whether a rifampin-free antibiotic regimen can be as effective as a rifampin-containing regimen for adults with staphylococcal prosthetic valve endocarditis.
-
Improving health and quality of life for patients recovering from infective endocarditis through cardiac rehabilitation
This study is testing if joining a cardiac rehabilitation program can help people recovering from infective endocarditis feel healthier and improve their quality of life.
-
Echocardiography versus no echocardiography for Staphylococcus aureus bloodstream infection with VIRSTA score <3
This trial tests whether it is safe to skip routine echocardiography in adults hospitalized with Staphylococcus aureus bloodstream infection who have a VIRSTA score under 3.
-
Barts Endocarditis Registry
This registry collects health, imaging, microbiology, treatment, and outcome information from adults with infective endocarditis seen at Barts Heart Centre to learn which approaches work best.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.